The Utility of Initial Procalcitonin and Procalcitonin Clearance for Prediction of Bacterial Infection and Outcome in Critically Ill Patients with Autoimmune Diseases: a Prospective Observational Study

Overview

Journal BMC Anesthesiol

Publisher Biomed Central

Specialty Anesthesiology

Date 2015 Oct 9

PMID 26446077

Citations 5

Authors

Yan Shi

Jin-Min Peng

Xiao-Yun Hu

Yao Wang

Affiliations

Soon will be listed here.

Abstract

Background: The diagnostic value of procalcitonin (PCT) for patients with autoimmune diseases (AID) remains controversial and few studies focused on ICU patients. We sought to determine its diagnostic and prognostic values in this clowd.

Methods: A prospective observational study was conducted in AID patients admitted to the ICU. Serum PCT levels were measured on ICU admission and subsequently at days 1, 3, 5 and 7, and peak PCT levels within 24 h (PCTpeak) were analyzed the utility for bacterial infection. The relationship of PCTpeak and SOFA score and severity of sepsis was performed correlation analysis. The change of PCT over time reflected as PCT clearance was compared to ICU 28-day mortality.

Results: One hundred twelve patients were divided into bacterial infection group (group I, n = 54) and nonbacterial condition group (group II, n = 58). The median PCTpeak (range, μg/L) was higher in the group I than that in the group II (1.95 [0.38-37.56] vs. 0.64 [0.05-7.83], p = 0.002). PCTpeak had the best single predictor of bacterial infection (area under the curve [AUC], 0.902, p < 0.001) with a sensitivity of 79.6 % and a specificity of 89.6 % at the threshold of 0.94 μg/L. PCTpeak was also positive correlation with severity of sepsis (r = 0.731, p = 0.002), but its correlation with SOFA score was only found in subjects with bacterial infection (r = 0.798, p < 0.001). Importantly, the 5-day PCT clearance (PCTc-d5), rather than absolute PCT values, could earlier discriminate survivors (n = 73) from nonsurvivors (n = 39) (68.8 ± 9.8 vs. 21.8 ± 17.5 %, p < 0.001, respectively). PCTc-d5 < 50 % was an independent predictor of mortality (odds ratio 5.1, 95 % confidence interval 3.5 to 7.5; p = 0.001).

Conclusions: In critically ill patients with AID, elevated PCT levels are valuable for bacterial infection and are significantly positive correlation with the septic severity. Five-day PCT clearance may provide independent prognostic information. Larger, prospective trials are warranted to confirm the benefit.

Citing Articles

Procalcitonin Guided Antibiotic Stewardship.

Kiya G, Asefa E, Abebe G, Mekonnen Z Biomark Insights. 2024; 19:11772719241298197.

PMID: 39559409 PMC: 11571249. DOI: 10.1177/11772719241298197.

Procalcitonin for the early discrimination of fever etiology in patients with systemic autoimmune diseases attending the emergency department.

Covino M, Gallo A, Simeoni B, Murace C, Ibba F, Pero E Intern Emerg Med. 2022; 18(2):617-625.

PMID: 36414876 DOI: 10.1007/s11739-022-03154-y.

Diagnostic and Prognostic Value of Interleukin-6 in Emergency Department Sepsis Patients.

Yu B, Chen M, Zhang Y, Cao Y, Yang J, Wei B Infect Drug Resist. 2022; 15:5557-5566.

PMID: 36172624 PMC: 9512288. DOI: 10.2147/IDR.S384351.

Modestly Elevated Serum Procalcitonin Levels in Patients with Rheumatoid Arthritis Free of Active Infection.

Ng K, Yu H, Tseng H, Hsu C, Lu M Medicina (Kaunas). 2020; 56(10).

PMID: 33080909 PMC: 7603207. DOI: 10.3390/medicina56100545.

The Preseptic Period and Inflammatory Markers in the Prediction of the Course of Sepsis.

Boran O, Yazar F, Boran M, Urfalioglu A, Bakacak Z, Yildiz M Med Sci Monit. 2018; 24:3531-3539.

PMID: 29804126 PMC: 5998727. DOI: 10.12659/MSM.907687.

References

van der Heijde D, van t Hof M, van Riel P, van de Putte L . Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. 1993; 20(3):579-81. View

Bombardier C, Gladman D, Urowitz M, Caron D, Chang C . Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35(6):630-40. DOI: 10.1002/art.1780350606. View

Vincent J, Moreno R, Takala J, Willatts S, de Mendonca A, Bruining H . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22(7):707-10. DOI: 10.1007/BF01709751. View

Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross W . Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol. 1998; 25(8):1531-3. View

Luyt C, Guerin V, Combes A, Trouillet J, Ben Ayed S, Bernard M . Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2004; 171(1):48-53. DOI: 10.1164/rccm.200406-746OC. View

Calandra T, Cohen J . The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005; 33(7):1538-48. DOI: 10.1097/01.ccm.0000168253.91200.83. View

Sponholz C, Sakr Y, Reinhart K, Brunkhorst F . Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care. 2006; 10(5):R145. PMC: 1751067. DOI: 10.1186/cc5067. View

Tang B, Eslick G, Craig J, McLean A . Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007; 7(3):210-7. DOI: 10.1016/S1473-3099(07)70052-X. View

Kushimoto S, Shibata Y, Koido Y, Kawai M, Yokota H, Yamamoto Y . The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy. J Nippon Med Sch. 2007; 74(3):236-40. DOI: 10.1272/jnms.74.236. View

10.

Tamaki K, Kogata Y, Sugiyama D, Nakazawa T, Hatachi S, Kageyama G . Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol. 2007; 35(1):114-9. View

11.

Dellinger R, Levy M, Carlet J, Bion J, Parker M, Jaeschke R . Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2007; 34(1):17-60. PMC: 2249616. DOI: 10.1007/s00134-007-0934-2. View

12.

Horan T, Andrus M, Dudeck M . CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008; 36(5):309-32. DOI: 10.1016/j.ajic.2008.03.002. View

13.

De Pauw B, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group.... Clin Infect Dis. 2008; 46(12):1813-21. PMC: 2671227. DOI: 10.1086/588660. View

14.

Chen D, Chen Y, Ho W, Chen H, Shen G, Lan J . Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still's disease. Ann Rheum Dis. 2009; 68(6):1074-5. DOI: 10.1136/ard.2008.098335. View

15.

Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F . Adult-onset Still's disease. Rheumatol Int. 2009; 30(7):855-62. DOI: 10.1007/s00296-009-1291-y. View

16.

Seror R, Ravaud P, Bowman S, Baron G, Tzioufas A, Theander E . EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis. 2009; 69(6):1103-9. PMC: 2937022. DOI: 10.1136/ard.2009.110619. View

17.

Buhaescu I, Yood R, Izzedine H . Serum procalcitonin in systemic autoimmune diseases--where are we now?. Semin Arthritis Rheum. 2010; 40(2):176-83. DOI: 10.1016/j.semarthrit.2009.10.004. View

18.

Lanoix J, Bourgeois A, Schmidt J, Desblache J, Salle V, Smail A . Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus. Lupus. 2010; 20(2):125-30. DOI: 10.1177/0961203310378862. View

19.

Picariello C, Lazzeri C, Valente S, Chiostri M, Gensini G . Procalcitonin in acute cardiac patients. Intern Emerg Med. 2010; 6(3):245-52. DOI: 10.1007/s11739-010-0462-x. View

20.

Wu J, Lee S, Shen C, Hsieh Y, Yo P, Cheng H . Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: a systematic review and meta-analysis. Arthritis Rheum. 2012; 64(9):3034-42. DOI: 10.1002/art.34512. View